Extranodal nasal NK/T cell lymphoma Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

Regulatory Watchboard

10 events

Jun 2026Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

CStone Pharmaceuticals — PHASE3

TrialNOT YET RECRUITING

Apr 2026Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma

Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE1

TrialRECRUITING

Mar 2026Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma

Rong Tao — PHASE1, PHASE2

TrialNOT YET RECRUITING

Mar 2026PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL

Ruijin Hospital — PHASE2

TrialRECRUITING

Feb 2026Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

M.D. Anderson Cancer Center — PHASE1

TrialRECRUITING

Feb 2026A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

Electra Therapeutics Inc. — PHASE1

TrialRECRUITING

Feb 2026Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Sun Yat-sen University

TrialNOT YET RECRUITING

Feb 2026Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

LIANG WANG — PHASE2

TrialNOT YET RECRUITING

Jan 2026Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

WEI XU — PHASE2

TrialNOT YET RECRUITING

Jan 2026EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas

Sun Yat-sen University — PHASE1, PHASE2

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Folotyn

Acrotech Biopharma LLC

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

24 active trials

1Phase 3

12Phase 2

3Phase 1

2N/A

2Unknown

4PHASE1, PHASE2

24Total recruiting

Search clinical trials for Extranodal nasal NK/T cell lymphoma →

Recent News & Research

No recent news articles indexed yet for Extranodal nasal NK/T cell lymphoma.
Search PubMed for Extranodal nasal NK/T cell lymphoma →

Browse all Extranodal nasal NK/T cell lymphoma news →

Specialist Network

Top 6 by expertise

Julie M Vose, OTR/L

University of Nebraska

📍 MANCHESTER, NH

Score 202 trials

Alison Moskowitz, MD, LCSW

Memorial Sloan Kettering Cancer Center

📍 FAIRFIELD, CT

Score 176 trials1 pub

Liang Wang, M.D.

Beijing Tongren Hospital

Score 124 trials

Helen E Heslop, MD, MD

Baylor College of Medicine

📍 HOUSTON, TX

Score 126 trials

Paolo Caimi, MD, M.D

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

📍 CLEVELAND, OH

Score 105 trials

Colleen Delaney, MD

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 OLD GREENWICH, CT

Score 93 trials

View all Extranodal nasal NK/T cell lymphoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰